[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100631677":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":41,"collaborators":10,"id":45,"slug":10,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":10,"eligibilityCriteria":50,"healthyVolunteers":46,"sex":51,"minAge":10,"maxAge":10,"enrollmentInfo":52,"targetDuration":10,"studyType":55,"phases":10,"briefSummary":56,"conditions":57,"keywords":10,"overallStatus":59,"whyStopped":10,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"Sohag University","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"patient with bladder cancer recieving radiotherapy and the treatment related events",null,[12],"Radiation: Radiotherapy followed by chemotherapy",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"RADIATION","Radiotherapy followed by chemotherapy","it is observational study for patient recieved defentive radiotherapy",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"heba elsagheer","CONTACT","0201062162612","hebaelsagheer@yahoo.com",[26],{"facility":27,"status":10,"city":28,"state":10,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Sohag University Hospitals","Sohag","Egypt","EG",{"type":32,"coordinates":33},"Point",[34,35],31.69478,26.55695,{"lat":35,"lon":34},[38],{"name":21,"role":22,"phone":39,"phoneExt":10,"email":40},"00201062162612","hebaelsagheer@yahoo.cm",{"type":42,"investigatorFullName":43,"investigatorTitle":44,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Heba Ali Elsagheer","proffesor clinical oncology","100631677",false,"NCT07503795","Outcomes of Definitive Radiotherapy for Bladder Cancer","Outcomes of Definitive Radiotherapy for Bladder Cancer: Real-World Experience From a Single Center","Inclusion Criteria:\n\n* Histologically confirmed urothelial carcinoma or variants; definitive intent radiotherapy\n\nExclusion Criteria:\n\n* Palliative radiotherapy only; prior radical cystectomy; or incomplete follow-up data.","ALL",{"count":53,"type":54},300,"ESTIMATED","OBSERVATIONAL","this is an observational study for patients with non metastatic bladder cancer recieving local radical radiotherapy with curative intent recieving radical dose of radiotherapy with or without chemosensitizer",[58],"Bladder Cancer (BC)","NOT_YET_RECRUITING","2026-03-26",{"date":62,"type":63},"2026-03-31","ACTUAL",{"date":65,"type":54},"2026-04-01",{"date":67,"type":54},"2027-06-01",{"name":5,"class":6},1]